These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2821884)

  • 1. 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.
    Wilson EJ; Medearis DN; Hansen LA; Rubin RH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1017-20. PubMed ID: 2821884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
    Katzenstein DA; Crane RT; Jordan MC
    J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Shanley JD; Morningstar J; Jordan MC
    Antimicrob Agents Chemother; 1985 Aug; 28(2):172-5. PubMed ID: 3010835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    Debs RJ; Montgomery AB; Brunette EN; DeBruin M; Shanley JD
    J Infect Dis; 1988 Feb; 157(2):327-31. PubMed ID: 2826613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.
    Rubin RH; Lynch P; Pasternack MS; Schoenfeld D; Medearis DN
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1975-9. PubMed ID: 2558616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
    Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.
    Collaborative DHPG Treatment Study Group
    N Engl J Med; 1986 Mar; 314(13):801-5. PubMed ID: 3005861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.
    Freitas VR; Smee DF; Chernow M; Boehme R; Matthews TR
    Antimicrob Agents Chemother; 1985 Aug; 28(2):240-5. PubMed ID: 3010840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization.
    Rubin RH; Wilson EJ; Barrett LV; Medearis DN
    Clin Immunol Immunopathol; 1986 Apr; 39(1):151-8. PubMed ID: 3004792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized cytomegalovirus (CMV) infection and CMV-induced pneumonitis in the rat: combined effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and specific antibody treatment.
    Stals FS; Wagenaar SS; Bruggeman CA
    Antiviral Res; 1994 Oct; 25(2):147-60. PubMed ID: 7847876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice.
    Neyts J; Balzarini J; Naesens L; De Clercq E
    J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men.
    Masur H; Lane HC; Palestine A; Smith PD; Manischewitz J; Stevens G; Fujikawa L; Macher AM; Nussenblatt R; Baird B
    Ann Intern Med; 1986 Jan; 104(1):41-4. PubMed ID: 3000248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.
    Smee DF; Burger RA; Coombs J; Huffman JH; Sidwell RW
    J Infect Dis; 1991 Nov; 164(5):958-61. PubMed ID: 1658160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of disseminated cytomegalovirus infection with 9-(1,3 dihydroxy-2-propoxymethyl)guanine: evidence of prolonged survival in patients with the acquired immunodeficiency syndrome.
    Kotler DP; Culpepper-Morgan JA; Tierney AR; Klein EB
    AIDS Res; 1986; 2(4):299-308. PubMed ID: 3028443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
    De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
    Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Newman C; Polk BF
    Ann Intern Med; 1987 Sep; 107(3):348-50. PubMed ID: 3039887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.